Resetting blood pressure by a closed-loop implanted chip system in normotensive rats.

A closed-loop implanted chip system was designed to control blood pressure without using drugs. The chip system instantaneously reset blood pressure by stimulating the left aortic depressor nerve according to the feedback signals of arterial blood pressure. The relationship between pressure signals and frequency of stimulation was identified in vitro and in vivo, and the efficiency of the chip system was evaluated in normal anesthetized Wistar rats. To determine whether the depressor effect of the chip was primarily independent on the bradycardia induced by the resetting, the effects of methyl atropine (1.5 g/kg, iv.) and bilateral vagotomy on depressor effect induced by the chip system were determined, respectively. The results indicated that the chip system worked well. The frequency of stimulus linearly increased following the elevation of pressure from 70 to 160 mm Hg. The frequency of the stimulus reached its maximum (100 Hz) when pressure exceeded 160 mm Hg, and the stimulation stopped when MAP was below 70 mm Hg. There were significant decreases in mean arterial pressure (MAP, -20.0+/-4.4 mm Hg) and heart rate (HR, -43.0+/-10.5 bpm) during the resetting in rats. After resetting, both MAP and HR recovered in a minute without any significant rebound. Pretreatment with either methyl atropine or bilateral vagotomy abolished the bradycardia effect but produced no significant effect on hypotension. The results demonstrated that the chip system successfully reset blood pressure in rats, and that the hypotension induced by the chip system was primarily independent on the bradycardia effect.

[1]  C. Lillehei,et al.  A NEW CONCEPT IN THE TREATMENT OF HYPERTENSION UTILIZING AN IMPLANTABLE ELECTRONIC DEVICE: "BAROPACER". , 1964, Biomedical sciences instrumentation.

[2]  J. Castania,et al.  Hemodynamic responses to electrical stimulation of the aortic depressor nerve in awake rats. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  Fernando Antônio Patriani Ferraz,et al.  Estimulação cerebral profunda no núcleo subtalâmico para doença de Parkinson , 2002 .

[4]  T. Lohmeier,et al.  Prolonged Activation of the Baroreflex Produces Sustained Hypotension , 2004, Hypertension.

[5]  F. Zhang,et al.  AT1 receptor in rostral ventrolateral medulla mediating blunted baroreceptor reflex in spontaneously hypertensive rats. , 2004, Acta pharmacologica Sinica.

[6]  K. Kario,et al.  Pressor effects of beta-blockers on standing blood pressure may be harmful for older patients with orthostatic hypertension. , 2002, Circulation.

[7]  M. Sugimachi,et al.  Dynamic transduction properties of in situ baroreceptors of rabbit aortic depressor nerve. , 1998, The American journal of physiology.

[8]  C. Lillehei,et al.  TREATMENT OF HYPERTENSION WITH AN IMPLANTABLE ELECTRONIC DEVICE. , 1965, JAMA.

[9]  D. Reis,et al.  Anatomical substrates for baroreflex sympathoinhibition in the rat , 2000, Brain Research Bulletin.

[10]  S. Nosaka,et al.  Inhibition of baroreflex vagal bradycardia by activation of the rostral ventrolateral medulla in rats. , 2000, American journal of physiology. Heart and circulatory physiology.

[11]  F G Rastgar,et al.  Speech recognition for wheelchair control. , 1983, Biomedical sciences instrumentation.

[12]  D. Naritoku,et al.  Intraoperative human vagus nerve compound action potentials , 2004, Acta neurologica Scandinavica.

[13]  A. Steptoe,et al.  Circulating Human Heat Shock Protein 60 in the Plasma of British Civil Servants: Relationship to Physiological and Psychosocial Stress , 2002, Circulation.

[14]  S. Morrison,et al.  The caudal ventrolateral medulla is a source of tonic sympathoinhibition , 1993, Brain Research.

[15]  T. Laitinen,et al.  Baroreflex sensitivity in essential and secondary hypertension , 2002, Clinical Autonomic Research.

[16]  G. Steil,et al.  Closed-loop insulin delivery-the path to physiological glucose control. , 2004, Advanced drug delivery reviews.

[17]  B. Lemmer,et al.  REDUCED BAROREFLEX SENSITIVITY AND BLUNTED ENDOGENOUS NITRIC OXIDE SYNTHESIS PRECEDE THE DEVELOPMENT OF HYPERTENSION IN TGR(mREN2)27 RATS , 2001, Chronobiology international.

[18]  W. Bennett Off-label use of approved drugs: therapeutic opportunity and challenges. , 2004, Journal of the American Society of Nephrology.